Session 3: Quality Assurance (WD-QA)
Tero Kivelä, MD will be coordinating this session. As a start, we challenge all centers to post their published results on their own websites. Then 10 centers will voluntarily share their prospective outcomes for choroidal melanoma and retinoblastoma. During the second working day, our specialty will discuss these efforts and decide how we should move forward.
Eye cancer specialists cannot know how to improve, unless they know the outcomes of their work. Current methods include periodic publication of research articles and didactic presentations at international meetings. These efforts are hampered by use of variable categorizations and lack of matching reference bases. Over the last decade, international standards (e.g. AJCC staging, ABS and AAPM radiation guidelines) have allowed for standardized comparisons. However, these standards remain underused and published works only offer a small sample of measurable outcomes. As a start, we encourage all centers to post their published results on their own websites. We also take steps to allow voluntary centers to share their prospective outcomes for choroidal melanoma and retinoblastoma. During these second working day, our specialty will discuss these efforts and decide how to move forward and expand.
Tero Kivelä, MD will be coordinating this session. As a start, we challenge all centers to post their published results on their own websites. Then 10 centers will voluntarily share their prospective outcomes for choroidal melanoma and retinoblastoma. During the second working day, our specialty will discuss these efforts and decide how we should move forward.
Eye cancer specialists cannot know how to improve, unless they know the outcomes of their work. Current methods include periodic publication of research articles and didactic presentations at international meetings. These efforts are hampered by use of variable categorizations and lack of matching reference bases. Over the last decade, international standards (e.g. AJCC staging, ABS and AAPM radiation guidelines) have allowed for standardized comparisons. However, these standards remain underused and published works only offer a small sample of measurable outcomes. As a start, we encourage all centers to post their published results on their own websites. We also take steps to allow voluntary centers to share their prospective outcomes for choroidal melanoma and retinoblastoma. During these second working day, our specialty will discuss these efforts and decide how to move forward and expand.
Convenor: Dr. Tero Kivelä
Dr. Tero Kivelä is Professor and Chair, Department of Ophthalmology, University of Helsinki, Finland. Tero will convene this section aimed at improving quality assurance by enabling outcome comparisons between centers. A doctor reported outcome (DRO) platform requires a data set that is meaningful, concise and easy to collect. This committee will present their work describing available methods of data collection, and sharing, for comment and approval by ISOO community. Volunteer centers will participate by sharing their outcomes in a closed system to form a basis for further discussion and critique at the time of the Sydney workshop. |